# Invesco Galaxy Bitcoin ETF: financial statements, quarterly

BTCO · CBOE · CIK 1855781 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/btco.md) · [Financials](/companies/btco/financials.md) · [Filings](/companies/btco/filings.md) · [Insiders](/companies/btco/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/btco/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.0](/filings/0000950170-25-067214.md) | [0.0](/filings/0000950170-24-092094.md) | [0.0](/filings/0000950170-24-122604.md) | [0.0 d](/filings/0000950170-25-029444.md) | [0.0](/filings/0000950170-25-067214.md) | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [0.0](/filings/0000950170-25-067214.md) | [0.0](/filings/0000950170-25-105150.md) | [(0.3)](/filings/0001193125-25-270289.md) | [(0.5) d](/filings/0001193125-26-083572.md) | [(0.4)](/filings/0001193125-26-209710.md) | [(0.3)](/filings/0001193125-26-338719.md) | [(0.4)](/filings/0001193125-25-270289.md) | [(0.4) d](/filings/0001193125-26-083572.md) | [(0.3)](/filings/0001193125-26-209710.md) | [(0.3)](/filings/0001193125-26-338719.md) |
| Net income | $m | [186](/filings/0000950170-25-067214.md) | [(49.1)](/filings/0000950170-25-105150.md) | [4.1](/filings/0001193125-25-270289.md) | [265 d](/filings/0001193125-26-083572.md) | [(73.4)](/filings/0001193125-26-209710.md) | [126](/filings/0001193125-26-338719.md) | [35.5](/filings/0001193125-25-270289.md) | [(161) d](/filings/0001193125-26-083572.md) | [(127)](/filings/0001193125-26-209710.md) | [(56.1)](/filings/0001193125-26-338719.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | period not labelled (2023-12-20) | period not labelled (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [0.1](/filings/0000950170-25-029444.md) | not reported | not reported | not reported | [0.0](/filings/0000950170-25-029444.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | not reported | [0.1](/filings/0000950170-25-029444.md) | [422](/filings/0000950170-24-058997.md) | [435](/filings/0000950170-24-092094.md) | [517](/filings/0000950170-24-122604.md) | [728](/filings/0001193125-26-083572.md) | [436](/filings/0000950170-25-067214.md) | [556](/filings/0000950170-25-105150.md) | [697](/filings/0001193125-25-270289.md) | [544](/filings/0001193125-26-338719.md) | [457](/filings/0001193125-26-209710.md) | [316](/filings/0001193125-26-338719.md) |
| Total liabilities | $m | not reported | [0.0](/filings/0000950170-25-029444.md) | [3.9](/filings/0000950170-24-058997.md) | not reported | [0.1](/filings/0000950170-24-122604.md) | [0.2](/filings/0001193125-26-083572.md) | [0.1](/filings/0000950170-25-067214.md) | [0.1](/filings/0000950170-25-105150.md) | [0.1](/filings/0001193125-25-270289.md) | [0.1](/filings/0001193125-26-338719.md) | [0.1](/filings/0001193125-26-209710.md) | [0.1](/filings/0001193125-26-338719.md) |
| Shareholders' equity | $m | [0.0](/filings/0001193125-26-083572.md) | [0.1](/filings/0001193125-26-083572.md) | not reported | not reported | not reported | [728](/filings/0001193125-26-083572.md) | not reported | not reported | not reported | [544](/filings/0001193125-26-338719.md) | [457](/filings/0001193125-26-209710.md) | [316](/filings/0001193125-26-338719.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(229)](/filings/0000950170-25-067214.md) | [(69.9) d](/filings/0000950170-25-105150.md) | [(77.3) d](/filings/0001193125-25-270289.md) | [54.4 d](/filings/0001193125-26-083572.md) | [218](/filings/0001193125-26-209710.md) | [6.7 d](/filings/0001193125-26-338719.md) | [(105) d](/filings/0001193125-25-270289.md) | [(8.4) d](/filings/0001193125-26-083572.md) | [(39.9)](/filings/0001193125-26-209710.md) | [85.3 d](/filings/0001193125-26-338719.md) |
| Share repurchases | $m | [227](/filings/0000950170-25-067214.md) | [38.5 d](/filings/0000950170-25-105150.md) | [22.3 d](/filings/0001193125-25-270289.md) | [116 d](/filings/0001193125-26-083572.md) | [246](/filings/0001193125-26-209710.md) | [67.4 d](/filings/0001193125-26-338719.md) | [5.1 d](/filings/0001193125-25-270289.md) | [60.3 d](/filings/0001193125-26-083572.md) | [15.2](/filings/0001193125-26-209710.md) | [96.5 d](/filings/0001193125-26-338719.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 5,370,000 at 2026-06-30, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-338719.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.